Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1988 Feb;207(2):115–119. doi: 10.1097/00000658-198802000-00001

Recurrent hepatic hemangiomas. Possible association with estrogen therapy.

R L Conter 1, W P Longmire Jr 1
PMCID: PMC1493383  PMID: 2829759

Abstract

Hemangiomas are the most common benign tumors occurring in the liver. However, the natural history of hepatic hemangiomas has not been well defined. Four patients (3 women, 1 man) with recurrent giant liver hemangiomas underwent either surgical or radiation therapy as initial treatment for the primary tumor. The average time until recurrence was 14 years, and each tumor weighed more than 600 g. Each of the female patients had been given chronic estrogen (Premarin) replacement therapy. Three of the four patients underwent surgical resection for intractable symptoms or progressive enlargement. It is believed that estrogen replacement therapy may play a role in the pathogenesis of these tumors. Furthermore, operative intervention should be considered in patients with recurrent giant liver hemangioma.

Full text

PDF
115

Images in this article

116Fig. 1.
on p.116
117Fig. 2.
on p.117
117Fig. 3.
on p.117
117Fig. 4.
on p.117
118Figs. 5A-C.
on p.118
118Figs. 5A-C.
on p.118

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
  2. Bruneton J. N., Drouillard J., Fenart D., Roux P., Nicolau A. Ultrasonography of hepatic cavernous haemangiomas. Br J Radiol. 1983 Nov;56(671):791–795. doi: 10.1259/0007-1285-56-671-791. [DOI] [PubMed] [Google Scholar]
  3. Christopherson W. M., Mays E. T., Barrows G. H. Liver tumors in women on contraceptive steroids. Obstet Gynecol. 1975 Aug;46(2):221–223. [PubMed] [Google Scholar]
  4. GORDON B. S., WOLF J., KRAUSE T., SHAI F. Peliosis hepatis and cholestasis following administration of norethandrolone. Am J Clin Pathol. 1960 Feb;33:156–165. doi: 10.1093/ajcp/33.2.156. [DOI] [PubMed] [Google Scholar]
  5. Glassberg A. B., Rosenbaum E. H. Letter: Oral contraceptives and malignant hepatoma. Lancet. 1976 Feb 28;1(7957):479–479. doi: 10.1016/s0140-6736(76)91494-x. [DOI] [PubMed] [Google Scholar]
  6. HENSON S. W., Jr, GRAY H. K., DOCKERTY M. B. Benign tumors of the liver. I. Adenomas. Surg Gynecol Obstet. 1956 Jul;103(1):23–30. [PubMed] [Google Scholar]
  7. Horvath E., Kovacs K., Ross R. C. Letter: Benign hepatoma in a young woman on contraceptive steroids. Lancet. 1974 Mar 2;1(7853):357–358. doi: 10.1016/s0140-6736(74)93111-0. [DOI] [PubMed] [Google Scholar]
  8. Kawarada Y., Mizumoto R. Surgical treatment of giant hemangioma of the liver. Am J Surg. 1984 Aug;148(2):287–291. doi: 10.1016/0002-9610(84)90239-3. [DOI] [PubMed] [Google Scholar]
  9. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977 Aug;73(2):386–394. [PubMed] [Google Scholar]
  10. Mays E. T., Christopherson W. M., Mahr M. M., Williams H. C. Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors. JAMA. 1976 Feb 16;235(7):730–732. [PubMed] [Google Scholar]
  11. McGiven A. R. Peliosis hepatis: case report and review of pathogenesis. J Pathol. 1970 Jul;101(3):283–285. doi: 10.1002/path.1711010312. [DOI] [PubMed] [Google Scholar]
  12. Meyer P., LiVolsi V., Cornog J. L. Letter: Hepatoblastoma associated with an oral contraceptive. Lancet. 1974 Dec 7;2(7893):1387–1387. doi: 10.1016/s0140-6736(74)92259-4. [DOI] [PubMed] [Google Scholar]
  13. Morley J. E., Myers J. B., Sack F. S., Kalk F., Epstein E. E., Lannon J. Enlargement of cavernous haemangioma associated with exogenous administration of oestrogens. S Afr Med J. 1974 Apr 6;48(16):695–697. [PubMed] [Google Scholar]
  14. Nissen E. D., Kent D. R., Nissen S. E., McRae D. M. Association of liver tumors with oral contraceptives. Obstet Gynecol. 1976 Jul;48(1):49–55. [PubMed] [Google Scholar]
  15. OCHSNER J. L., HALPERT B. Cavernous hemangioma of the liver. Surgery. 1958 Apr;43(4):577–582. [PubMed] [Google Scholar]
  16. SEWELL J. H., WEISS K. Spontaneous rupture of hemangioma of the liver. A review of the literature and presentation of illustrative case. Arch Surg. 1961 Nov;83:729–733. doi: 10.1001/archsurg.1961.01300170085016. [DOI] [PubMed] [Google Scholar]
  17. Trastek V. F., van Heerden J. A., Sheedy P. F., 2nd, Adson M. A. Cavernous hemangiomas of the liver: resect or observe? Am J Surg. 1983 Jan;145(1):49–53. doi: 10.1016/0002-9610(83)90165-4. [DOI] [PubMed] [Google Scholar]
  18. Winkler K., Poulsen H. Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol. 1975;10(7):699–704. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES